You've Tried Everything. You're Still Not Better. Here's What You Need to Know About Treatment-Resistant Depression.

You've done everything right.

You saw a doctor. You started medication. Maybe you tried more than one. Maybe you tried several going through the long, demoralizing process of waiting six weeks to find out something isn't working, then starting over.

You've maybe tried therapy. Lifestyle changes. Exercise. Sleep hygiene. Every tip in every article you've ever read.

And you're still struggling.

If that's your story, we need to say something to you directly: you are not failing treatment. Treatment may be failing you. And there is a name for what you're experiencing treatment-resistant depression and there are options designed specifically for people in your situation.

What Is Treatment-Resistant Depression?

Treatment-resistant depression, or TRD, is a clinical term used to describe major depressive disorder that has not responded adequately to at least two different antidepressant treatments, used at appropriate doses for an appropriate amount of time.

This is not a rare situation. Research suggests that roughly 30% of people with major depressive disorder will experience treatment resistance meaning their depression doesn't respond adequately to the medications that work for most people.

That's not a small number. That's millions of people.

And yet it often goes unrecognized or worse, patients are made to feel like they're not trying hard enough, or that their depression is somehow uniquely hopeless. Neither of those things is true.

What is true is this: your brain may be wired in a way that requires a different approach than what's been tried so far.

The Problem With "Try Another Antidepressant"

When standard antidepressants don't work, the most common response is to try another one. And sometimes, eventually, something does work. For some people, the fifth or sixth medication is the one.

But for people with TRD, cycling through medications isn't just frustrating it's physically and emotionally depleting. The waiting. The side effects. The hope followed by disappointment. The way your life is on hold while you're going through this process.

And the longer someone lives with untreated or undertreated depression, the more it affects their relationships, their work, their physical health, their sense of who they are.

At some point, "let's try another SSRI" is not a good enough answer.

Where Spravato Fits In

Spravato (esketamine) was specifically developed and FDA-approved for treatment-resistant depression. This isn't an off-label use or an experimental approach it went through rigorous clinical trials and demonstrated meaningful efficacy in patients who had not responded to other treatments.

Here's what sets it apart:

It works on a different brain pathway. Most antidepressants work on serotonin, norepinephrine, or dopamine systems. Spravato works on glutamate a neurotransmitter involved in synaptic plasticity and neural connectivity. For many people with TRD, this completely different mechanism is the key.

It works faster. Traditional antidepressants take weeks to build up and start working. Spravato can produce antidepressant effects within hours to days for many patients.

It's designed to be used alongside an oral antidepressant so it's not replacing what you're already doing, it's augmenting it with a different approach.

It's covered by many insurance plans including Medicaid when the clinical criteria for TRD are met. This is not a treatment that's only available to people who can pay out of pocket.

Who Is a Candidate?

Spravato is FDA-approved for adults with:

• Treatment-resistant depression defined as inadequate response to at least two oral antidepressants
• Major depressive disorder with active suicidal ideation or behavior, in a medically supervised setting

It is not right for everyone. Your provider will evaluate your full history, your current medications, your medical history, and other factors to determine whether Spravato is appropriate for you. This is a thorough process and it should be.

Questions Worth Asking Your Provider

If you've been dealing with depression that isn't responding to treatment, these are the conversations worth having:

"Do I meet the clinical criteria for treatment-resistant depression?" "Have I been on my current medications at adequate doses for enough time to make a real determination?" "Am I a candidate for Spravato, and can we go through the specifics of what that would look like?" "What does the research say about response rates, and what's a realistic expectation for someone in my situation?" "What happens if Spravato doesn't work what are the next options?"

A good provider will engage with all of these questions directly and honestly.

You Are Not Out of Options

Living with treatment-resistant depression is one of the most exhausting, demoralizing experiences there is because you're fighting something that isn't responding to what's supposed to fix it, while also managing the depression itself.

But you are not out of options. The landscape of treatment for TRD has changed significantly in the last several years, and Spravato is a meaningful part of that change.

You don't have to accept that this is just how it's going to be.

We're here to have the honest conversation about where you are, what you've tried, and what might actually help. Treatment-resistant doesn't mean treatment-impossible. It means we need a different approach.

Let's find it together.